Dr. Sharon McGuinness:

As to what is happening across Europe, the biological agents regulations come from the European directive, and that was amended. That is what all member states will put into force in their countries. We have looked at this and have talked to colleagues across Europe because we are in various committees and working groups with them. Many member states are doing similar in that they are identifying Covid as a specific illness for particular sectors. That is derived directly from the biological agents regulations, which we all have to transpose and implement in that respect. It is a challenging one, and across European countries very often the issue is still driven by public health. Again, the nature of the reporting systems in place in countries is driven by the fact that there are different systems in place, not just necessarily under occupational health but in general reporting as well, so they are all interconnected. We are very much in line with the majority of the member states that have looked at this as a specific illness in the context of specific sectors such as healthcare.